IRF6

This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants.
Full Name
Interferon Regulatory Factor 6
Function
Probable DNA-binding transcriptional activator. Key determinant of the keratinocyte proliferation-differentiation switch involved in appropriate epidermal development (By similarity).
Plays a role in regulating mammary epithelial cell proliferation (By similarity).
May regulate WDR65 transcription (By similarity).
Biological Process
Cell developmentIEA:Ensembl
Cranial skeletal system developmentIEA:Ensembl
Immune system processManual Assertion Based On ExperimentIBA:GO_Central
Keratinocyte differentiationIEA:Ensembl
Keratinocyte proliferationIEA:Ensembl
Limb developmentIEA:Ensembl
Mammary gland epithelial cell differentiationISS:UniProtKB
Negative regulation of cell population proliferationManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of transcription by RNA polymerase IIManual Assertion Based On ExperimentIDA:NTNU_SB
Positive regulation of transcription, DNA-templatedISS:UniProtKB
Regulation of transcription by RNA polymerase IIManual Assertion Based On ExperimentIBA:GO_Central
Roof of mouth developmentIEA:Ensembl
Cellular Location
Cytoplasm; Nucleus. Translocates to nucleus in response to an activating signal.
Involvement in disease
Van der Woude syndrome 1 (VWS1):
An autosomal dominant developmental disorder characterized by lower lip pits, cleft lip and/or cleft palate.
Popliteal pterygium syndrome (PPS):
An autosomal dominant disorder characterized by oro-facial, skin and genital anomalies. Expressivity is variable. Clinical features include cleft lip/palate, lower lip cysts, syngnathia, congenital ankyloblepharon filiforme in some cases, bifid scrotum, hypoplastic scrotum, hypoplastic uterus, talipes equinovarus.
Non-syndromic orofacial cleft 6 (OFC6):
A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum.
PTM
Phosphorylated. Phosphorylation status depends on the cell cycle and is a signal for ubiquitination and proteasome-mediated degradation.
View more

Anti-IRF6 antibodies

+ Filters
Loading...
Target: IRF6
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human, Monkey, Dog
Clone: CBYY-I2146
Application*: WB, IH
Target: IRF6
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Dog, Rat
Clone: CBYY-I1970
Application*: WB, IH, IF, F
Target: IRF6
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYY-I1953
Application*: WB, IH, IF, F
Target: IRF6
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-I1920
Application*: WB, IF, F
Target: IRF6
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBYY-I1904
Application*: WB
Target: IRF6
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human, Mouse
Clone: CBYY-I0617
Application*: WB
Target: IRF6
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-I0384
Application*: WB
Target: IRF6
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Rat, Dog
Clone: 2C10
Application*: WB, F, IH, IF, P
Target: IRF6
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 2A12
Application*: WB, P, F, IC, IF
Target: IRF6
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 1D4
Application*: F, IF, WB
Target: IRF6
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 1B9
Application*: WB
More Infomation
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
  • AActivation
  • AGAgonist
  • APApoptosis
  • BBlocking
  • BABioassay
  • BIBioimaging
  • CImmunohistochemistry-Frozen Sections
  • CIChromatin Immunoprecipitation
  • CTCytotoxicity
  • CSCostimulation
  • DDepletion
  • DBDot Blot
  • EELISA
  • ECELISA(Cap)
  • EDELISA(Det)
  • ESELISpot
  • EMElectron Microscopy
  • FFlow Cytometry
  • FNFunction Assay
  • GSGel Supershift
  • IInhibition
  • IAEnzyme Immunoassay
  • ICImmunocytochemistry
  • IDImmunodiffusion
  • IEImmunoelectrophoresis
  • IFImmunofluorescence
  • IGImmunochromatography
  • IHImmunohistochemistry
  • IMImmunomicroscopy
  • IOImmunoassay
  • IPImmunoprecipitation
  • ISIntracellular Staining for Flow Cytometry
  • LALuminex Assay
  • LFLateral Flow Immunoassay
  • MMicroarray
  • MCMass Cytometry/CyTOF
  • MDMeDIP
  • MSElectrophoretic Mobility Shift Assay
  • NNeutralization
  • PImmunohistologyp-Paraffin Sections
  • PAPeptide Array
  • PEPeptide ELISA
  • PLProximity Ligation Assay
  • RRadioimmunoassay
  • SStimulation
  • SESandwich ELISA
  • SHIn situ hybridization
  • TCTissue Culture
  • WBWestern Blot
online inquiry
Online Inquiry
Happy Holidays
Happy Holidays close ad